The Pistoia Alliance has introduced its newest project—IDMP Common Core Ontology. The project aims to augment the existing Identification of Medicinal Products (IDMP) framework as defined by the International Standards Organization.
The IDMP Common Core Ontology will be devised as a common core ontology under FAIR data principles. The ontology will enable semantic interoperability and consistent representation of medicinal products across regulatory bodies, companies, and regions. An IDMP-compliant ontology with machine-ready data will support the move to automate the drug submissions to the European Medicines Agency (EMA) process. It will improve efficiency and patient safety, reduce costs and time burden, and drive innovation in the drug development pipeline.
The project's first phase will involve developing a minimal viable product (MVP) focused on the substance domain. It will demonstrate value, provide use cases, and standardize data language. Subsequently, it will be extended to further IDMP data domains for other regulated substances, including vaccines, gene technology, and botanical substances.
Click here to read the original article published by Contract Pharma.
Please give your feedback on this article or share a similar story for publishing by clicking here.
